Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction
Brent Gudenkauf(Johns Hopkins University), Allison G. Hays(Johns Hopkins University), Lena Mathews(Johns Hopkins University), Erin D. Michos(Johns Hopkins University), Gabriel E. Shaya(Johns Hopkins University), Monica Mukherjee(Johns Hopkins University), Kavita Sharma(Johns Hopkins University), José Madrazo(Johns Hopkins University), Sanjiv J. Shah(Northwestern University)
Cited by 22
Related Papers
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
|Circulation|2014|1k
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
|Nature Medicine|2021|599